Platelet transfusion therapy in the management of dengue patients: Role of fundus examination - 18/08/22
Doi : 10.1016/j.tracli.2022.02.002
Manish Jain a, Naveen Bansal b, ⁎ 
, Manish Raturi c, Yashik Bansal d
, Manish Raturi c, Yashik Bansal d a Department of Ophthalmology, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India
b Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India
c Department of Immunohematology and Blood Transfusion, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jolly Grant, Dehradun, Uttarakhand, India
d Department of Microbiology, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India
⁎Corresponding author at: Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India.Department of Transfusion Medicine, VCSG Government Institute of Medical Science and ResearchSrinagar, UttarakhandIndia
Le texte complet de cet article est disponible en PDF.
Plan
© 2022
Société française de transfusion sanguine (SFTS). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 29 - N° 3
P. 275-276 - août 2022 Retour au numéro
Article précédent
- Towards equitable and sustainable availability of blood products in Zimbabwe: An analysis of strengths, weaknesses, opportunities and challenges
- K. Denhere, T. Dzinamarira, N. Tungwarara, V. Kampira, I. Chitungo, K. Mataruka, S. Mukwenha, G. Musuka, G. Murewanhema
- Several screening cells combination could predict red blood cell alloantibody?
- X. Li
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?